Updated Follow-up Analysis in the REP 401 Protocol: Treatment of HBeAg Negative Chronic HBV Infection with REP 2139 or REP 2165, Tenofovir Disoproxil Fumarate and Pegylated Interferon alpha-2a

著录项

• 来源
  《Journal of viral hepatitis.》 |2018年第s2期|共1页
• 作者

  Bazinet M.; Pantea V.; Placinta G.; Moscalu I.; Cebotarescu V.; Cojuhari L.; Jimbei P.; Iarovoi L.; Smesnoi V.; Musteata T.; Jucov A.; Krawczyk A.; Vaillant A.;

  展开▼
• 作者单位

  Replicor Montreal PQ Canada;

  State Univ Med &

  Pharm Nicolae Testemitanu Fac Postgrad Educ Dept Infect Dis Kishinev Moldova;

  State Univ Med &

  Pharm Nicolae Testemitanu Fac Postgrad Educ Dept Infect Dis Kishinev Moldova;

  ARENSIA Exploratory Med Republican Clin Hosp Phase Unit 1 Dusseldorf Germany;

  State Univ Med &

  Pharm Nicolae Testemitanu Fac Postgrad Educ Dept Infect Dis Kishinev Moldova;

  State Univ Med &

  Pharm Nicolae Testemitanu Fac Postgrad Educ Dept Infect Dis Kishinev Moldova;

  Infect Clin Hosp Toma Ciorba Kishinev Moldova;

  State Univ Med &

  Pharm Nicolae Testemitanu Fac Postgrad Educ Dept Infect Dis Kishinev Moldova;

  Infect Clin Hosp Toma Ciorba Kishinev Moldova;

  Infect Clin Hosp Toma Ciorba Kishinev Moldova;

  ARENSIA Exploratory Med Republican Clin Hosp Phase Unit 1 Dusseldorf Germany;

  Univ Klinikum Essen Inst Virol Essen Germany;

  Replicor Montreal PQ Canada;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 传染病;
• 关键词